The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

A twice-yearly injectable drug for the prevention of HIV infection has been approved by the United States’ Food and Drug ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

General, Winnie Byanyima, has called for a drastic and transparent reduction in the cost of lenacapavir, a twice-yearly ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

The Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that has been shown to act as ...

The U.S. approved a twice-yearly HIV prevention shot that’s highly effective, but concerns about cost, access, and global ...

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV ...